Home > Healthcare & Medical Devices > Cystic Fibrosis Therapeutics Market > Table of Contents

Cystic Fibrosis Therapeutics Market Size By Treatment Method (Medications [Drug Class {CFTR Modulators, Mucolytics, Bronchodilators, Pancreatic Enzyme Supplements}, Route of Administration {Oral Drugs, Inhaled drugs}], Devices), By Distribution Channel (Hospitals, Retail Pharmacies), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

  • Report ID: GMI5118
  • Published Date: Sep 2021
  • Report Format: PDF

Report Content

Chapter 1   Methodology

1.1    Methodology

1.2    Market definitions

1.3    Forecast parameters

1.4    Data sources

1.4.1    Secondary

1.4.1.1    Paid sources

1.4.1.2    Unpaid sources

1.4.2    Primary

Chapter 2   Executive Summary

2.1    Cystic fibrosis therapeutics industry 360° synopsis, 2016 – 2027

2.1.1    Business trends

2.1.2    Treatment method trends

2.1.3    Distribution channel trends

2.1.4    Regional trends

Chapter 3   Cystic Fibrosis Therapeutics Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016 - 2027

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Rise in incidence of cystic fibrosis

3.3.1.2    Advancements in therapeutics for treatment of cystic fibrosis in developed regions

3.3.1.3    Rising awareness and adoption of treatment procedures developing regions

3.3.2    Industry pitfalls and challenges

3.3.2.1    Low awareness in developing nations

3.3.2.2    High cost of surgical treatment

3.4    Growth potential analysis

3.4.1    By treatment method

3.4.2    By distribution channel

3.5    COVID-19 impact analysis

3.6    Porter’s analysis

3.7    Competitive landscape, 2020

3.7.1    Competitive matrix analysis, 2020

3.8    PESTEL analysis

Chapter 4   Cystic Fibrosis Therapeutics Market, By Treatment Method

4.1    Key segment trends

4.2    Medications

4.2.1    Market size, by region, 2016 – 2027

4.2.2    Market size, by Drug class, 2016 – 2027

4.2.2.1    CFTR modulators

4.2.2.1.1    Market size, by region, 2016 – 2027

4.2.2.2    Mucolytics

4.2.2.2.1    Market size, by region, 2016 – 2027

4.2.2.3    Bronchodilators

4.2.2.3.1    Market size, by region, 2016 – 2027

4.2.2.4    Pancreatic enzyme supplements

4.2.2.4.1    Market size, by region, 2016 – 2027

4.2.2.5    Others

4.2.2.5.1    Market size, by region, 2016 – 2027

4.2.3    Market Size, by route of administration, 2016 – 2027

4.2.3.1    Oral drugs

4.2.3.1.1    Market size, by region, 2016 – 2027

4.2.3.2    Inhaled drugs

4.2.3.2.1    Market size, by region, 2016 – 2027

4.3    Devices

4.3.1    Market size, by region, 2016 – 2027

4.4    Others

4.4.1    Market size, by region, 2016 – 2027

Chapter 5   Cystic Fibrosis Therapeutics Market, By Distribution Channel

5.1    Key segment trends

5.2    Hospitals

5.2.1    Market size, by region, 2016 – 2027

5.3    Retail pharmacies

5.3.1    Market size, by region, 2016 – 2027

5.4    Others

5.4.1    Market size, by region, 2016 – 2027

Chapter 6   Cystic Fibrosis Therapeutics Market, By Region

6.1    Key regional trends

6.2    North America

6.2.1    Market size, by country, 2016 – 2027

6.2.2    Market size, by treatment method, 2016 – 2027

6.2.2.1    Medications market size, by drug class, 2016 – 2027

6.2.2.2    Medications market size, by route of administration, 2016 – 2027

6.2.3    Market size, by distribution channel, 2016 – 2027

6.2.4    U.S.

6.2.4.1    Market size, by treatment method, 2016 – 2027

6.2.4.1.1    Medications market size, by drug class, 2016 – 2027

6.2.4.1.2    Medications market size, by route of administration, 2016 – 2027

6.2.4.2    Market size, by distribution channel, 2016 – 2027

6.2.5    Canada

6.2.5.1    Market size, by treatment method, 2016 – 2027

6.2.5.1.1    Medications market size, by drug class, 2016 – 2027

6.2.5.1.2    Medications market size, by route of administration, 2016 – 2027

6.2.5.2    Market size, by distribution channel, 2016 – 2027

6.3    Europe

6.3.1    Market size, by country, 2016 – 2027

6.3.2    Market size, by treatment method, 2016 – 2027

6.3.2.1    Medications market size, by drug class, 2016 – 2027

6.3.2.2    Medications market size, by route of administration, 2016 – 2027

6.3.3    Market size, by distribution channel, 2016 – 2027

6.3.4    Germany

6.3.4.1    Market size, by treatment method, 2016 – 2027

6.3.4.1.1    Medications market size, by drug class, 2016 – 2027

6.3.4.1.2    Medications market size, by route of administration, 2016 – 2027

6.3.4.2    Market size, by distribution channel, 2016 – 2027

6.3.5    France

6.3.5.1    Market size, by treatment method, 2016 – 2027

6.3.5.1.1    Medications market size, by drug class, 2016 – 2027

6.3.5.1.2    Medications market size, by route of administration, 2016 – 2027

6.3.5.2    Market size, by distribution channel, 2016 – 2027

6.3.6    UK

6.3.6.1    Market size, by treatment method, 2016 – 2027

6.3.6.1.1    Medications market size, by drug class, 2016 – 2027

6.3.6.1.2    Medications market size, by route of administration, 2016 – 2027

6.3.6.2    Market size, by distribution channel, 2016 – 2027

6.3.7    Italy

6.3.7.1    Market size, by treatment method, 2016 – 2027

6.3.7.1.1    Medications market size, by drug class, 2016 – 2027

6.3.7.1.2    Medications market size, by route of administration, 2016 – 2027

6.3.7.2    Market size, by distribution channel, 2016 – 2027

6.3.8    Spain

6.3.8.1    Market size, by treatment method, 2016 – 2027

6.3.8.1.1    Medications market size, by drug class, 2016 – 2027

6.3.8.1.2    Medications market size, by route of administration, 2016 – 2027

6.3.8.2    Market size, by distribution channel, 2016 – 2027

6.4    Latin America

6.4.1    Market size, by country, 2016 – 2027

6.4.2    Market size, by treatment method, 2016 – 2027

6.4.2.1    Medications market size, by drug class, 2016 – 2027

6.4.2.2    Medications market size, by route of administration, 2016 – 2027

6.4.3    Market size, by distribution channel, 2016 – 2027

6.4.4    Brazil

6.4.4.1    Market size, by treatment method, 2016 – 2027

6.4.4.1.1    Medications market size, by drug class, 2016 – 2027

6.4.4.1.2    Medications market size, by route of administration, 2016 – 2027

6.4.4.2    Market size, by distribution channel, 2016 – 2027

6.4.5    Mexico

6.4.5.1    Market size, by treatment method, 2016 – 2027

6.4.5.1.1    Medications market size, by drug class, 2016 – 2027

6.4.5.1.2    Medications market size, by route of administration, 2016 – 2027

6.4.5.2    Market size, by distribution channel, 2016 – 2027

6.5    Rest of the world

6.5.1    Market size, by country, 2016 – 2027

6.5.2    Market size, by treatment method, 2016 – 2027

6.5.2.1    Medications market size, by drug class, 2016 – 2027

6.5.2.2    Medications market size, by route of administration, 2016 – 2027

6.5.3    Market size, by distribution channel, 2016 – 2027

6.5.4    Australia

6.5.4.1    Market size, by treatment method, 2016 – 2027

6.5.4.1.1    Medications market size, by drug class, 2016 – 2027

6.5.4.1.2    Medications market size, by route of administration, 2016 – 2027

6.5.4.2    Market size, by distribution channel, 2016 – 2027

6.5.5    South Africa

6.5.5.1    Market size, by treatment method, 2016 – 2027

6.5.5.1.1    Medications market size, by drug class, 2016 – 2027

6.5.5.1.2    Medications market size, by route of administration, 2016 – 2027

6.5.5.2    Market size, by distribution channel, 2016 – 2027

Chapter 7   Company Profiles

7.1    Strategy dashboard, 2020

7.2    Vertex Pharmaceuticals Incorporated

7.2.1    Business overview

7.2.2    Financial data

7.2.3    Product landscape

7.2.4    Strategic outlook

7.2.5    SWOT analysis

7.3    Roche

7.3.1    Business overview

7.3.2    Financial data

7.3.3    Product landscape

7.3.4    Strategic outlook

7.3.5    SWOT analysis

7.4    Nestle Health Science

7.4.1    Business overview

7.4.2    Financial data

7.4.3    Product landscape

7.4.4    Strategic outlook

7.4.5    SWOT analysis

7.5    Abbvie

7.5.1    Business overview

7.5.2    Financial data

7.5.3    Product landscape

7.5.4    Strategic outlook

7.5.5    SWOT analysis

7.6    Viatris Inc

7.6.1    Business overview

7.6.2    Financial data

7.6.3    Product landscape

7.6.4    Strategic outlook

7.6.5    SWOT analysis

7.7    Horizon Therapeutics plc

7.7.1    Business overview

7.7.2    Financial data

7.7.3    Product landscape

7.7.4    Strategic outlook

7.7.5    SWOT analysis

7.8    Gilead

7.8.1    Business overview

7.8.2    Financial data

7.8.3    Product landscape

7.8.4    Strategic outlook

7.8.5    SWOT analysis

7.9    Chiesi Farmaceutici

7.9.1    Business overview

7.9.2    Financial data

7.9.3    Product landscape

7.9.4    Strategic outlook

7.9.5    SWOT analysis

7.10    Pharmaxis Ltd

7.10.1    Business overview

7.10.2    Financial data

7.10.3    Product landscape

7.10.4    Strategic outlook

7.10.5    SWOT analysis

7.11    Teva Pharmaceuticals

7.11.1    Business overview

7.11.2    Financial data

7.11.3    Product landscape

7.11.4    Strategic outlook

7.11.5    SWOT analysis
 

Data Tables

TABLE 1    Cystic fibrosis therapeutics industry 360° synopsis, 2016 – 2027

TABLE 2    Cystic fibrosis therapeutics market, 2016-2027 (USD Million)

TABLE 3    Cystic fibrosis therapeutics market, by treatment method, 2016-2027 (USD Million)

TABLE 4    Cystic fibrosis medications market, by drug class, 2016-2027 (USD Million)

TABLE 5    Cystic fibrosis medications market, by route of administration, 2016-2027 (USD Million)

TABLE 6    Cystic fibrosis therapeutics market, by distribution channel, 2016-2027 (USD Million)

TABLE 7    Cystic fibrosis therapeutics market, by region, 2016-2027 (USD Million)

TABLE 8    Industry impact forces

TABLE 9    Medications market size, by region, 2016-2027 (USD Million)

TABLE 10    CFTR modulators market size, by region, 2016-2027 (USD Million)

TABLE 11    Mucolytics market size, by region, 2016-2027 (USD Million)

TABLE 12    Bronchodilators market size, by region, 2016-2027 (USD Million)

TABLE 13    Pancreatic enzyme supplements market size, by region, 2016-2027 (USD Million)

TABLE 14    Others market size, by region, 2016-2027 (USD Million)

TABLE 15    Oral Drugs market size, by region, 2016-2027 (USD Million)

TABLE 16    Inhaled Drugs market size, by region, 2016-2027 (USD Million)

TABLE 17    Devices market size, by region, 2016-2027 (USD Million)

TABLE 18    Others market size, by region, 2016-2027 (USD Million)

TABLE 19    Hospitals market size, by region, 2016-2027 (USD Million)

TABLE 20    Retail pharmacies market size, by region, 2016-2027 (USD Million)

TABLE 21    Other market size, by region, 2016-2027 (USD Million)

TABLE 22    North America cystic fibrosis therapeutics market size, by country, 2016-2027 (USD Million)

TABLE 23    North America cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)

TABLE 24    North America cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)

TABLE 25    North America cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)

TABLE 26    North America cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)

TABLE 27    U.S. Cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)

TABLE 28    U.S. cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)

TABLE 29    U.S. cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)

TABLE 30    U.S. Cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)

TABLE 31    Canada Cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)

TABLE 32    Canada cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)

TABLE 33    Canada cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)

TABLE 34    Canada Cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)

TABLE 35    Europe Cystic fibrosis therapeutics market size, by country, 2016-2027 (USD Million)

TABLE 36    Europe Cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)

TABLE 37    Europe cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)

TABLE 38    Europe cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)

TABLE 39    Europe Cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)

TABLE 40    Germany Cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)

TABLE 41    Germany cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)

TABLE 42    Germany cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)

TABLE 43    Germany Cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)

TABLE 44    France Cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)

TABLE 45    France cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)

TABLE 46    France cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)

TABLE 47    France Cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)

TABLE 48    UK Cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)

TABLE 49    UK cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)

TABLE 50    UK cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)

TABLE 51    UK Cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)

TABLE 52    Italy Cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)

TABLE 53    Italy cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)

TABLE 54    Italy cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)

TABLE 55    Italy cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)

TABLE 56    Spain cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)

TABLE 57    Spain cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)

TABLE 58    Spain cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)

TABLE 59    Spain cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)

TABLE 60    Latin America Cystic fibrosis therapeutics market size, by country, 2016-2027 (USD Million)

TABLE 61    Latin America Cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)

TABLE 62    Latin America cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)

TABLE 63    Latin America cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)

TABLE 64    Latin America Cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)

TABLE 65    Brazil Cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)

TABLE 66    Brazil cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)

TABLE 67    Brazil cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)

TABLE 68    Brazil Cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)

TABLE 69    Mexico Cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)

TABLE 70    Mexico cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)

TABLE 71    Mexico cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)

TABLE 72    Mexico Cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)

TABLE 73    RoW cystic fibrosis therapeutics market size, by country, 2016-2027 (USD Million)

TABLE 74    RoW cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)

TABLE 75    RoW cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)

TABLE 76    RoW cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)

TABLE 77    RoW cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)

TABLE 78    Australia cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)

TABLE 79    Australia cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)

TABLE 80    Australia cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)

TABLE 81    Australia cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)

TABLE 82    South Africa cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)

TABLE 83    South Africa cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)

TABLE 84    South Africa cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)

TABLE 85    South Africa cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)
 

Charts & Figures

FIG. 1   Industry segmentation

FIG. 2   Global cystic fibrosis therapeutics market size, 2016 - 2027 (USD Million)

FIG. 3   Growth potential analysis, by treatment method

FIG. 4   Growth potential analysis, by distribution channel

FIG. 5   Porter’s analysis

FIG. 6   Competitive matrix analysis, 2020

FIG. 7   PESTEL analysis

FIG. 8   Key segment trends, by treatment method

FIG. 9   Key segment trends, by distribution channel

FIG. 10 Key regional trends, by region

FIG. 11 Strategy dashboard, 2020
 

Authors: Sumant Ugalmugle, Rupali Swain

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2020
  • Companies covered: 10
  • Tables & Figures: 96
  • Countries covered: 11
  • Pages: 100

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount